Found: 8
Select item for more details and to access through your institution.
Epigenetics of hepatocellular carcinoma.
- Published in:
- Clinical & Translational Medicine, 2019, v. 8, n. 1, p. 1, doi. 10.1186/s40169-019-0230-0
- By:
- Publication type:
- Article
Epigenetics of hepatocellular carcinoma.
- Published in:
- Clinical & Translational Medicine, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40169-019-0230-0
- By:
- Publication type:
- Article
Frequent upregulation of G9a promotes RelB-dependent proliferation and survival in multiple myeloma.
- Published in:
- Experimental Hematology & Oncology, 2020, v. 9, n. 1, p. 1, doi. 10.1186/s40164-020-00164-4
- By:
- Publication type:
- Article
Epigenetics in cancer stem cells.
- Published in:
- Molecular Cancer, 2017, v. 16, p. 1, doi. 10.1186/s12943-017-0596-9
- By:
- Publication type:
- Article
Histone‐lysine N‐methyltransferase EHMT2 (G9a) inhibition mitigates tumorigenicity in Myc‐driven liver cancer.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 11, p. 2275, doi. 10.1002/1878-0261.13417
- By:
- Publication type:
- Article
Maximizing Efficiency of Artificial Intelligence‐Driven Drug Combination Optimization through Minimal Resolution Experimental Design.
- Published in:
- Advanced Therapeutics, 2020, v. 3, n. 4, p. 1, doi. 10.1002/adtp.201900122
- By:
- Publication type:
- Article
IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐Cov‐2) with digital drug development.
- Published in:
- Bioengineering & Translational Medicine, 2021, v. 6, n. 1, p. 1, doi. 10.1002/btm2.10196
- By:
- Publication type:
- Article
Rational drug combination design in patient-derived avatars reveals effective inhibition of hepatocellular carcinoma with proteasome and CDK inhibitors.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02436-9
- By:
- Publication type:
- Article